江波龙：接受中信证券调研

Group 1 - Jiangbolong (SZ 301308) announced a research meeting with CITIC Securities scheduled for October 20 and 22, 2025, where the company's Vice General Manager and Board Secretary Xu Gangling will participate [1] - For the year 2024, Jiangbolong's revenue composition is entirely from the storage industry, accounting for 100.0% [1] - As of the report date, Jiangbolong's market capitalization stands at 93.1 billion yuan [1] Group 2 - In 2023, China's innovative pharmaceuticals have generated 80 billion USD in overseas licensing deals [1] - The secondary market for biomedicine is experiencing a surge, while the primary market is facing challenges in fundraising [1]